Baseline characteristics
| Total (n = 91) | DC Group (n = 24) | TT Group(n = 42) | DAPT Group (n = 25) | P | |
|---|---|---|---|---|---|
| Age (mean) (SD) (yr) | 72.27 (SD, 8.1) | 72.4 (SD, 6.7) | 72.6 (SD, 9) | 71.6 (SD, 8.3) | .9 |
| Female sex (No.) (%) | 16 (17.6) | 6 (25) | 8 (19) | 2 (8) | .119 |
| CHAsDS2-VASc score (mean) | 5.3 (SD, 1.3) | 5.5 (SD, 1.1) | 5.1 (SD, 1.4) | 5.3 (SD, 1.4) | .548 |
| HAS-BLED score (mean) | 3.9 (SD, 0.9) | 3.8 (SD, 0.6) | 3.8 (SD, 0.9) | 4.24 (SD, 0.9) | .168 |
| Hypertension (No.) (%) | 79 (86.8) | 22 (91.7) | 35 (83.3) | 22 (88) | .616 |
| Diabetes mellitus (No.) (%) | 44 (48.4) | 14 (58.3) | 15 (35.7) | 15 (60) | .082 |
| Dyslipidemia (No.) (%) | 68 (74.7) | 20 (83.3) | 31 (73.8) | 17 (68) | .459 |
| Heart failure (No.) (%) | 41 (45.1) | 14 (58.3) | 17 (40.5) | 10 (40) | .313 |
| Smoker (No.) (%) | 23 (25.27) | 6 (25) | 7 (16.7) | 10 (40) | .1 |
| Peripheral arteriopathy (No.) (%) | 18 (18.5) | 3 (12.5) | 6 (25) | 9 (0.36) | .57 |
| Serum creatinine levels (No.) (%) | |||||
| <1.5 mg/dL | 79 (86.8) | 19 (79.2) | 40 (95.2) | 20 (80) | .956 |
| ≥1.5 mg/d | 2 (13.2) | 5 (20.8) | 2 (4.8) | 5 (20) |